{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:14:36Z","timestamp":1793654076406,"version":"4.5.1"},"reference-count":19,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Inflammation plays an important role in chimeric antigen receptor (CAR) T-cell therapy, especially in the pathophysiology of cytokine-release syndrome (CRS) and immune effector cell\u2013associated neurotoxicity syndrome (ICANS). Clonal hematopoiesis of indetermined potential (CHIP) has also been associated with chronic inflammation. The relevance of CHIP in the context of CAR T-cell treatment is widely unknown. We evaluated the prevalence of CHIP, using a targeted deep sequencing approach, in a cohort of patients with relapsed\/refractory (r\/r) B-cell non-Hodgkin lymphoma before and after CAR T-cell treatment. The aim was to define the prevalence and variation of CHIP over time and to assess the influence on clinical inflammation syndromes (CRS\/ICANS), cytopenia, and outcome. Overall, 32 patients were included. CHIP was found in 11 of 32 patients (34%) before CAR T-cell therapy. CHIP progression was commonly detected in the later course. Patients with CHIP showed a comparable response rate to CAR T-cell treatment but had an improved overall survival (not reached vs 265 days, P = .003). No significant difference was observed in terms of the occurrence and severity of CRS\/ICANS, therapeutic use of tocilizumab and glucocorticosteroids, paraclinical markers of inflammation (with the exception of ferritin), or dynamics of hematopoietic recovery. CHIP is commonly observed in patients undergoing CD19-directed CAR T-cell therapy and is not associated with an inferior outcome.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005747","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T22:05:11Z","timestamp":1641852311000},"page":"1941-1946","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":63,"title":["Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment"],"prefix":"10.1182","volume":"6","author":[{"given":"Raphael","family":"Teipel","sequence":"first","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kroschinsky","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kramer","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Kretschmann","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Egger-Heidrich","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kr\u00fcger","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"},{"name":"Deutsches Konsortium f\u00fcr Translationale Krebsforschung, Standort Dresden, Deutsches Krebsforschungszentrum, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Ruhnke","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Herold","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0271-4894","authenticated-orcid":false,"given":"Sebastian","family":"Stasik","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Sockel","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Middeke","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Trautmann-Grill","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"},{"name":"National Center for Tumor Disease, Dresden, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-2048","authenticated-orcid":false,"given":"Christian","family":"Thiede","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"},{"name":"Deutsches Konsortium f\u00fcr Translationale Krebsforschung, Standort Dresden, Deutsches Krebsforschungszentrum, Heidelberg, Germany;"},{"name":"AgenDix GmbH, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"von Bonin","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden, Dresden, Germany;"},{"name":"Deutsches Konsortium f\u00fcr Translationale Krebsforschung, Standort Dresden, Deutsches Krebsforschungszentrum, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"issue":"6","key":"2022032115285903700_B1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","article-title":"CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade","volume":"24","author":"Giavridis","year":"2018","journal-title":"Nat Med."},{"issue":"15","key":"2022032115285903700_B2","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/bloodadvances.2020002509","article-title":"Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies","volume":"4","author":"Jain","year":"2020","journal-title":"Blood Adv."},{"issue":"6","key":"2022032115285903700_B3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat Med."},{"issue":"24","key":"2022032115285903700_B4","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1182\/blood.2020010543","article-title":"CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed\/refractory large B-cell lymphoma","volume":"138","author":"Rejeski","year":"2021","journal-title":"Blood."},{"issue":"1","key":"2022032115285903700_B5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood."},{"issue":"26","key":"2022032115285903700_B6","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med."},{"key":"2022032115285903700_B7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"Tet2 restrains inflammatory gene expression in macrophages","volume":"55","author":"Cull","year":"2017","journal-title":"Exp Hematol."},{"issue":"6327","key":"2022032115285903700_B8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science."},{"issue":"6","key":"2022032115285903700_B9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell Stem Cell."},{"key":"2022032115285903700_B10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.exphem.2017.11.002","article-title":"An inflammatory environment containing TNF\u03b1 favors Tet2-mutant clonal hematopoiesis","volume":"59","author":"Abegunde","year":"2018","journal-title":"Exp Hematol."},{"issue":"10","key":"2022032115285903700_B11","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1038\/s41375-021-01337-8","article-title":"Clonal hematopoiesis and its emerging effects on cellular therapies","volume":"35","author":"von Bonin","year":"2021","journal-title":"Leukemia."},{"issue":"15","key":"2022032115285903700_B12","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1182\/bloodadvances.2021004554","article-title":"Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy","volume":"5","author":"Miller","year":"2021","journal-title":"Blood Adv."},{"key":"2022032115285903700_B13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bdq.2017.12.001","article-title":"An optimized targeted next-generation sequencing approach for sensitive detection of single nucleotide variants","volume":"15","author":"Stasik","year":"2018","journal-title":"Biomol Detect Quantif."},{"issue":"14","key":"2022032115285903700_B14","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J Clin Oncol."},{"issue":"NOV","key":"2022032115285903700_B15","first-page":"502","article-title":"Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment","volume":"7","author":"Kovtonyuk","year":"2016","journal-title":"Front Immunol."},{"issue":"1","key":"2022032115285903700_B16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4049\/jimmunol.1700559","article-title":"The loss of TET2 promotes CD8+ T cell memory differentiation","volume":"200","author":"Carty","year":"2018","journal-title":"J Immunol."},{"issue":"7709","key":"2022032115285903700_B17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells","volume":"558","author":"Fraietta","year":"2018","journal-title":"Nature."},{"issue":"1","key":"2022032115285903700_B18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1470-2045(16)30627-1","article-title":"Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study","volume":"18","author":"Gillis","year":"2017","journal-title":"Lancet Oncol."},{"issue":"4","key":"2022032115285903700_B19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/6\/1941\/1881754\/advancesadv2021005747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/6\/1941\/1881754\/advancesadv2021005747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T15:29:23Z","timestamp":1647876563000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/6\/1941\/483413\/Prevalence-and-variation-of-CHIP-in-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,3,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005747","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]}}}